Literature DB >> 25464484

Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial.

Annelise C Costanza1, Samuel D Moscavitch2, Hugo C C Faria Neto3, Evandro T Mesquita1.   

Abstract

Entities:  

Keywords:  Failure; Heart; Inflammation; Microbiota; Probiotic; Systolic

Mesh：

Year:  2014        PMID： 25464484     DOI： 10.1016/j.ijcard.2014.11.034

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  31 in total

Review 1.  The gut microbiome and heart failure: A better gut for a better heart.

Authors:  Maxime Branchereau; Rémy Burcelin; Christophe Heymes
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

Review 2.  Targeting the Microbiome in Heart Failure.

Authors:  Allyson Zabell; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-04

Review 3.  Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  J Card Fail       Date:  2015-10-03       Impact factor: 5.712

Review 4.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

Review 5.  The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure.

Authors:  Kelley M Anderson; Erin P Ferranti; Emily Couvillon Alagha; Emma Mykityshyn; Casey E French; Carolyn Miller Reilly
Journal:  Heart Fail Rev       Date:  2022-06-21       Impact factor: 4.654

6.  Gut Microbiota Involvement in Ventricular Remodeling Post-Myocardial Infarction.

Authors:  Amy McMillan; Stanley L Hazen
Journal:  Circulation       Date:  2019-01-29       Impact factor: 29.690

7.  Heat-Killed Lactobacillus reuteri GMNL-263 Inhibits Systemic Lupus Erythematosus-Induced Cardiomyopathy in NZB/W F1 Mice.

Authors:  Peng Xiang; Chih-Yang Huang; Yu-Lan Yeh; Min-Chi Lu; Bruce Chi-Kang Tsai; Bor-Show Tzang; Shiu-Min Cheng; Xiaoyong Zhang; Liang-Yo Yang; B Mahalakshmi; Wei-Wen Kuo
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

Review 8.  Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.

Authors:  Petra Mamic; Thanat Chaikijurajai; W H Wilson Tang
Journal:  J Mol Cell Cardiol       Date:  2020-12-09       Impact factor: 5.000

Review 9.  The Gut in Heart Failure: Current Knowledge and Novel Frontiers.

Authors:  Antonella Gallo; Noemi Macerola; Angela Maria Favuzzi; Maria Anna Nicolazzi; Antonio Gasbarrini; Massimo Montalto
Journal:  Med Princ Pract       Date:  2022-01-28       Impact factor: 2.132

10.  Multi-Strain Probiotics Inhibit Cardiac Myopathies and Autophagy to Prevent Heart Injury in High-Fat Diet-Fed Rats.

Authors:  Chao-Hung Lai; Cheng-Chih Tsai; Wei-Wen Kuo; Tsung-Jung Ho; Cecilia-Hsuan Day; Pei-ying Pai; Li-Chin Chung; Chun-Chih Huang; Hsueh-Fang Wang; Po-Hsiang Liao; Chih-Yang Huang
Journal:  Int J Med Sci       Date:  2016-03-30       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.